<DOC>
	<DOCNO>NCT00189241</DOCNO>
	<brief_summary>The purpose study evaluate long-term sustained clearance rate superficial basal cell carcinoma 5 year period follow treatment imiquimod</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Imiquimod 5 % Cream Superficial Basal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Have one superficial BCC primary tumour Minimum tumour area 0.5cm2 , maximum diameter 2.0cm . If female child bear potential , negative pregnancy test willing use medically acceptable method contraception . Evidence clinically significant , unstable medical condition . Evidence Gorlin syndrome , metastatic tumour tumour high probability metastatic spread , within last 5 year malignant cancer skin target tumour site . Have receive defined treatment tumour site surround area . Any dermatological disease target tumour site surround area . Have systemic bacterial viral infection within 2 week prior study initiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Aldara</keyword>
	<keyword>Superficial Basal Cell Carcinoma</keyword>
	<keyword>Long-Term Study</keyword>
</DOC>